A naturally inspired industrial biotechnology route to the manufacture of a novel biopolymer with unique properties

Synthomer和Ingenza将继续在TSB共同资助的可行性研究中开始的合作。Synthomer已经确定了一种产品的市场缺口，如果使用工业生物技术制造，这种产品将具有更好的性能，并且没有现有制造技术制造的类似材料的缺点。他们预计，这种产品将迅速吸收到他们的一个关键市场领域，由于改进的特点。Synthomer是全球五大乳液和特种聚合物供应商之一，在这一目标市场拥有丰富的经验。Ingenza是一家生物技术推动者，使用专有技术开发新型生物工艺。Ingenza将通过创建能够生产Synthomer产品的转基因微生物来开发生物工艺。在成功完成该项目后，Synthomer和Ingenza希望进行持久的合作，以优化这种独特产品的可持续生产生物工艺。

Synthomer and Ingenza will continue the collaboration begun in a successful TSB co-funded Feasibility Study. Synthomer have identified a market gap for a product which if made using industrial biotechnology would have improved properties and none of the drawbacks of similar materials made by existing manufacturing technologies. They anticipate that this product would be rapidly assimilated into one of their key market areas due the improved characteristics. Synthomer are a top 5 global supplier of emulsion and specialty polymer company with vast experience in this target market. Ingenza are a biotechnology enabler who develop novel bioprocesses using proprietary technologies. Ingenza will develop a bioprocess by creating a GM microorganism capable of manufacturing Synthomer's product. Following the successful completion of the programme, Synthomer and Ingenza expect to enter into a lasting collaboration to optimise a sustainable manufacturing bioprocess for this unique product.